302 related articles for article (PubMed ID: 32320410)
1. Impact of cancer-associated mutations in Hsh155/SF3b1 HEAT repeats 9-12 on pre-mRNA splicing in Saccharomyces cerevisiae.
Kaur H; Groubert B; Paulson JC; McMillan S; Hoskins AA
PLoS One; 2020; 15(4):e0229315. PubMed ID: 32320410
[TBL] [Abstract][Full Text] [Related]
2. SF3B1/Hsh155 HEAT motif mutations affect interaction with the spliceosomal ATPase Prp5, resulting in altered branch site selectivity in pre-mRNA splicing.
Tang Q; Rodriguez-Santiago S; Wang J; Pu J; Yuste A; Gupta V; Moldón A; Xu YZ; Query CC
Genes Dev; 2016 Dec; 30(24):2710-2723. PubMed ID: 28087715
[TBL] [Abstract][Full Text] [Related]
3. SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast.
Carrocci TJ; Zoerner DM; Paulson JC; Hoskins AA
Nucleic Acids Res; 2017 May; 45(8):4837-4852. PubMed ID: 28062854
[TBL] [Abstract][Full Text] [Related]
4. Disclosing the Impact of Carcinogenic SF3b Mutations on Pre-mRNA Recognition Via All-Atom Simulations.
Borišek J; Saltalamacchia A; Gallì A; Palermo G; Molteni E; Malcovati L; Magistrato A
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31640290
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of Hsh155/SF3b1 interactions with the U2 snRNA/branch site duplex.
Carrocci TJ; Paulson JC; Hoskins AA
RNA; 2018 Aug; 24(8):1028-1040. PubMed ID: 29752352
[TBL] [Abstract][Full Text] [Related]
6. Cus2 enforces the first ATP-dependent step of splicing by binding to yeast SF3b1 through a UHM-ULM interaction.
Talkish J; Igel H; Hunter O; Horner SW; Jeffery NN; Leach JR; Jenkins JL; Kielkopf CL; Ares M
RNA; 2019 Aug; 25(8):1020-1037. PubMed ID: 31110137
[TBL] [Abstract][Full Text] [Related]
7. Chemical Inhibition of Pre-mRNA Splicing in Living Saccharomyces cerevisiae.
Hansen SR; Nikolai BJ; Spreacker PJ; Carrocci TJ; Hoskins AA
Cell Chem Biol; 2019 Mar; 26(3):443-448.e3. PubMed ID: 30639260
[TBL] [Abstract][Full Text] [Related]
8. Structural insights into how Prp5 proofreads the pre-mRNA branch site.
Zhang Z; Rigo N; Dybkov O; Fourmann JB; Will CL; Kumar V; Urlaub H; Stark H; Lührmann R
Nature; 2021 Aug; 596(7871):296-300. PubMed ID: 34349264
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch Point.
Darman RB; Seiler M; Agrawal AA; Lim KH; Peng S; Aird D; Bailey SL; Bhavsar EB; Chan B; Colla S; Corson L; Feala J; Fekkes P; Ichikawa K; Keaney GF; Lee L; Kumar P; Kunii K; MacKenzie C; Matijevic M; Mizui Y; Myint K; Park ES; Puyang X; Selvaraj A; Thomas MP; Tsai J; Wang JY; Warmuth M; Yang H; Zhu P; Garcia-Manero G; Furman RR; Yu L; Smith PG; Buonamici S
Cell Rep; 2015 Nov; 13(5):1033-45. PubMed ID: 26565915
[TBL] [Abstract][Full Text] [Related]
10. The pre-mRNA splicing and transcription factor Tat-SF1 is a functional partner of the spliceosome SF3b1 subunit via a U2AF homology motif interface.
Loerch S; Leach JR; Horner SW; Maji D; Jenkins JL; Pulvino MJ; Kielkopf CL
J Biol Chem; 2019 Feb; 294(8):2892-2902. PubMed ID: 30567737
[TBL] [Abstract][Full Text] [Related]
11. Structures of SF3b1 reveal a dynamic Achilles heel of spliceosome assembly: Implications for cancer-associated abnormalities and drug discovery.
Maji D; Grossfield A; Kielkopf CL
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194440. PubMed ID: 31707043
[TBL] [Abstract][Full Text] [Related]
12. Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms.
Cazzola M; Rossi M; Malcovati L;
Blood; 2013 Jan; 121(2):260-9. PubMed ID: 23160465
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors.
Je EM; Yoo NJ; Kim YJ; Kim MS; Lee SH
Int J Cancer; 2013 Jul; 133(1):260-5. PubMed ID: 23280334
[TBL] [Abstract][Full Text] [Related]
14. Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures.
Jenkins JL; Kielkopf CL
Trends Genet; 2017 May; 33(5):336-348. PubMed ID: 28372848
[TBL] [Abstract][Full Text] [Related]
15. Molecular architecture of the human 17S U2 snRNP.
Zhang Z; Will CL; Bertram K; Dybkov O; Hartmuth K; Agafonov DE; Hofele R; Urlaub H; Kastner B; Lührmann R; Stark H
Nature; 2020 Jul; 583(7815):310-313. PubMed ID: 32494006
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.
Kesarwani AK; Ramirez O; Gupta AK; Yang X; Murthy T; Minella AC; Pillai MM
Oncogene; 2017 Feb; 36(8):1123-1133. PubMed ID: 27524419
[TBL] [Abstract][Full Text] [Related]
17. Broad variation in response of individual introns to splicing inhibitors in a humanized yeast strain.
Hunter O; Talkish J; Quick-Cleveland J; Igel H; Tan A; Kuersten S; Katzman S; Donohue JP; S Jurica M; Ares M
RNA; 2024 Jan; 30(2):149-170. PubMed ID: 38071476
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated mutations in SF3B1 disrupt the interaction between SF3B1 and DDX42.
Zhao B; Li Z; Qian R; Liu G; Fan M; Liang Z; Hu X; Wan Y
J Biochem; 2022 Jul; 172(2):117-126. PubMed ID: 35652295
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.
Makishima H; Visconte V; Sakaguchi H; Jankowska AM; Abu Kar S; Jerez A; Przychodzen B; Bupathi M; Guinta K; Afable MG; Sekeres MA; Padgett RA; Tiu RV; Maciejewski JP
Blood; 2012 Apr; 119(14):3203-10. PubMed ID: 22323480
[TBL] [Abstract][Full Text] [Related]
20. CUS1, a suppressor of cold-sensitive U2 snRNA mutations, is a novel yeast splicing factor homologous to human SAP 145.
Wells SE; Neville M; Haynes M; Wang J; Igel H; Ares M
Genes Dev; 1996 Jan; 10(2):220-32. PubMed ID: 8566755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
